455 related articles for article (PubMed ID: 24571724)
41. Genotype-specific cortisol production associated with Cushing's syndrome adenoma with PRKACA mutations.
Baba R; Oki K; Gomez-Sanchez CE; Otagaki Y; Itcho K; Kobuke K; Kodama T; Nagano G; Ohno H; Yoneda M; Hattori N
Mol Cell Endocrinol; 2021 Dec; 538():111456. PubMed ID: 34520814
[TBL] [Abstract][Full Text] [Related]
42. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
43. Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy.
Beauregard C; Dickstein G; Lacroix A
Treat Endocrinol; 2002; 1(2):79-94. PubMed ID: 15765624
[TBL] [Abstract][Full Text] [Related]
44. PKA Cα subunit mutation triggers caspase-dependent RIIβ subunit degradation via Ser
Weigand I; Ronchi CL; Vanselow JT; Bathon K; Lenz K; Herterich S; Schlosser A; Kroiss M; Fassnacht M; Calebiro D; Sbiera S
Sci Adv; 2021 Feb; 7(8):. PubMed ID: 33608270
[TBL] [Abstract][Full Text] [Related]
45. Mosaic PRKACA duplication causing a novel and distinct phenotype of early-onset Cushing's syndrome and acral cutaneous mucinosis.
McGlacken-Byrne SM; Abdelmaksoud A; Haini M; Palm L; Ashworth M; Li J; Wang W; Wang X; Wang J; Callaghan B; Kinsler VA; Faravelli F; Dattani MT
Eur J Endocrinol; 2022 Dec; 187(6):K55-K61. PubMed ID: 36691942
[TBL] [Abstract][Full Text] [Related]
46. Paradoxical inhibitory effect of serotonin on cortisol production from adrenocortical lesions causing Cushing's syndrome.
Louiset E; Cartier D; Contesse V; Duparc C; Lihrmann I; Young J; Bertherat J; Reznik Y; Kuhn JM; Laquerrière A; Vaudry H; Lefebvre H
Endocr Res; 2004 Nov; 30(4):951-4. PubMed ID: 15666851
[TBL] [Abstract][Full Text] [Related]
47. Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations.
Nanba K; Omata K; Tomlins SA; Giordano TJ; Hammer GD; Rainey WE; Else T
Eur J Endocrinol; 2016 Aug; 175(2):K1-6. PubMed ID: 27165862
[TBL] [Abstract][Full Text] [Related]
48. Primary bilateral adrenal nodular disease with Cushing's syndrome: varying aetiology.
Jarial KDS; Walia R; Nahar U; Bhansali A
BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28739615
[TBL] [Abstract][Full Text] [Related]
49. [A case of Cushing's syndrome due to bilateral multiple adrenal adenomas].
Ashida S; Kataoka S; Yamasaki I; Yamashita M; Ohashi Y; Morioka M; Shuin T
Hinyokika Kiyo; 1997 Aug; 43(8):567-70. PubMed ID: 9310779
[TBL] [Abstract][Full Text] [Related]
50. Pathogenesis of benign unilateral adrenocortical tumors: focus on cAMP/PKA pathway.
Weigand I
Minerva Endocrinol; 2019 Mar; 44(1):25-32. PubMed ID: 29963826
[TBL] [Abstract][Full Text] [Related]
51. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
[TBL] [Abstract][Full Text] [Related]
52. Lipofuscin Accumulation in Cortisol-Producing Adenomas With and Without PRKACA Mutations.
Angelousi A; Szarek E; Shram V; Kebebew E; Quezado M; Stratakis CA
Horm Metab Res; 2017 Oct; 49(10):786-792. PubMed ID: 28834963
[TBL] [Abstract][Full Text] [Related]
53. Etiopathogeny of Primary Adrenal Hypercortisolism.
Vélayoudom-Céphise FL; Haissaguerre M; Tabarin A
Front Horm Res; 2016; 46():39-53. PubMed ID: 27212135
[TBL] [Abstract][Full Text] [Related]
54. Identification of a clinically homogenous subgroup of benign cortisol-secreting adrenocortical tumors characterized by alterations of the protein kinase A (PKA) subunits and high PKA activity.
Vincent-Dejean C; Cazabat L; Groussin L; Perlemoine K; Fumey G; Tissier F; Bertagna X; Bertherat J
Eur J Endocrinol; 2008 Jun; 158(6):829-39. PubMed ID: 18505904
[TBL] [Abstract][Full Text] [Related]
55. Primary adrenal causes of Cushing's syndrome. Diagnosis and surgical management.
Perry RR; Nieman LK; Cutler GB; Chrousos GP; Loriaux DL; Doppman JL; Travis WD; Norton JA
Ann Surg; 1989 Jul; 210(1):59-68. PubMed ID: 2742414
[TBL] [Abstract][Full Text] [Related]
56. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
[TBL] [Abstract][Full Text] [Related]
57. Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
Stratakis CA; Boikos SA
Nat Clin Pract Endocrinol Metab; 2007 Nov; 3(11):748-57. PubMed ID: 17955016
[TBL] [Abstract][Full Text] [Related]
58. Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism.
Kamilaris CDC; Stratakis CA; Hannah-Shmouni F
Front Endocrinol (Lausanne); 2021; 12():632543. PubMed ID: 33776926
[TBL] [Abstract][Full Text] [Related]
59. Clinical and Molecular Characteristics of PRKACA L206R Mutant Cortisol-Producing Adenomas in Korean Patients.
Jang I; Kim SJ; Song RY; Kim K; Choi S; Lee JS; Gwon MK; Seong MW; Lee KE; Kim JH
Endocrinol Metab (Seoul); 2021 Dec; 36(6):1287-1297. PubMed ID: 34852451
[TBL] [Abstract][Full Text] [Related]
60. Possibly simultaneous primary aldosteronism and preclinical Cushing's syndrome in a patient with double adenomas of right adrenal gland.
Saito T; Ikoma A; Saito T; Tamemoto H; Suminaga Y; Yamada S; Kawakami M; Suzuki T; Sasano H; Ishikawa SE
Endocr J; 2007 Apr; 54(2):287-93. PubMed ID: 17379961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
